SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- (Australia and Oceania) Bruce CV Campbell, MBBS PhD
Melbourne Health
Principal Investigator - (Europe) Marc Ribo, MD
Vall d'Hebron University Hospital, Barcelona
Principal Investigator - Amrou Sarraj, MD
Case Western Reserve University - University Hospitals Cleveland Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Liverpool Hospital - South Western Sydney Clinical School
Liverpool, New South Wales, Australia
- the Royal Adelaide Hospital (rah)
Adelaide, South Australia, Australia
- Royal Melbourne Hospital
Melbourne, Victoria, Australia
- University of Alberta
Edmonton, Alberta, Canada
- University Health Network - Toronto Western Hospital
Toronto, Ontario, Canada
- Christchurch Hospital
Christchurch, Canterbury, New Zealand
- Hospital Universitario Germans Trias I Pujol
Badalona, Spain
- Hospital Clínic I Provincial de Barcelona
Barcelona, Spain
- Hospital Universitari Vall D'Hebron
Barcelona, Spain
- Hospital Universitari de Bellvitge
Barcelona, Spain
- Hospital Clínico Universitario de Valladolid
Valladolid, Spain
- Universität Basel
Basel, Switzerland
- Kaiser Permanente
Los Angeles, California, United States
- Baptist Health
Jacksonville, Florida, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Ascension St. Vincent Hospital
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Spectrum Health Hospital
Grand Rapids, Michigan, United States
- Westchester Medical Center
Valhalla, New York, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Riverside Methodist Hospital - Ohiohealth
Columbus, Ohio, United States
- Abington Jefferson Health
Abington, Pennsylvania, United States
- the Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Semmes Murphey Clinic - University of Tennessee Health Science Center
Memphis, Tennessee, United States
- Dell Seton Medical Center at the University of Texas at Austin
Austin, Texas, United States
- Valley Baptist Medical Center
Harlingen, Texas, United States
- the University of Texas Health Science Center at Houston
Houston, Texas, United States
- Ascension Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Oct 2019
- Primary completion
- 20 Nov 2022
- Completion
- 16 Nov 2023
- Last update posted
- 21 Nov 2024
- Registered enrollment
- 352
- Registry id
- NCT03876457
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.